Available until February 1, 2026

Pulmonary function tests are extremely useful in both diagnosing and managing patients with respiratory disease. In addition to a medical history, physical exam and imaging studies, they give us a great deal of information of the pulmonary physiology and help us understand why patients have various respiratory symptoms. However, there are quite a number of pulmonary function tests available to us and which tests we should order can be confusing. Do we know when spirometry, lung volumes or diffusion capacity will be useful for evaluating the various pulmonary conditions? Our guest for this podcast is Dr. Alexander Niven, from the Division of Pulmonary and Critical Care Medicine at the Mayo Clinic and he’ll provide answers to these questions and more as we discuss “How to Use Pulmonary Function Tests Effectively”.

Available until February 1, 2026

Severe acute respiratory syndrome coronavirus 2, also known as COVID-19, is a novel virus with a rapidly changing genotype. It’s responsible for over a million deaths so far. One of every 300 Americans have died as a result of the virus and infection with COVID-19, and it has been responsible for a reduction in life expectancy in the U.S. for both 2021 and 2022. There are 4 widely available, approved vaccines in the United States, yet an inadequate number of individuals have been immunized and very few are still wearing protective masks. The consequences of this include continued excess morbidity and mortality as well as the development of a variety of new variants of the virus. Our guest for this podcast is Greg A. Poland, M.D., an internist, and the director of vaccine research at the Mayo Clinic. He’s also the lead author of an article published in Mayo Clinic Proceedings in December 2022. The article is entitled “Year 3 of COVID-19: Harsh Truths, Brutal Realities and Glimmers of Hope”. We’ll be discussing some of the key points from this article.

February 28 - March 1, 2024 - Hilton Hotel- Rochester, Minnesota

This course offers Live (in-person) and Livestream (virtual) attendance options

This three-day course is designed to provide the latest diagnostic and treatment strategies for comprehensive wound management. The program is multidisciplinary with faculty representing various wound-related fields. Multiple educational formats are used, including didactic sessions, hands-on demonstrations, and case presentations that offer comprehensive wound-management strategies (from basics to high-level). The course meets the continuing education needs of a range of wound care providers, from novices to experts.

March 21 - 23, 2024 - Mayo Clinic Florida

This course offers Live (in-person) and Livestream (virtual) attendance options

With both a Neurosurgery track and a Neurology track, this course is designed as a review of targeting, programming and surgical approaches and operative techniques pertaining to surgical treatment of epilepsy, facial pain and movement disorders such as Parkinson’s disease, essential tremor and dystonia. The course will offer a cadaver workshop as well as augmented reality and advanced programming workshops as well. The course is designed for neurosurgeons, pain specialists, neurologists, physician assistants, residents, fellows, and mid-level providers interested in movement disorders, to provide a global approach to the movement disorder patients.

September 23, 2023 - Courtyard Marriot - Mankato, Minnesota

Mayo Osteopathic Research and Education (MORE) Conference is a regional conference with an emphasis on Osteopathic Manual Treatment (OMT) and Osteopathic Research. It is a hub for education and networking for physicians and residents who provide OMT in the Upper Midwest. It focuses on hands-on Osteopathic education for physicians and residents.

Available until July 31, 2024 - Online CME Course

Breast cancer risk assessment entails understanding clinical and genomic risk factors. Available risk calculation models provide population level risk with limitations in implementation in clinical practice. We need to advance the paradigm and transition to precision prevention and personalized risk stratification. With accurate risk assessment clinicians can optimize clinical benefits including surveillance imaging and risk reducing medication options. New research on the use of single nucleotide polymorphisms and polygenic risk score could be useful for stratifying and predicting individualized breast cancer risk and enhance shard decision making opportunities in management of women at increased risk for breast cancer